SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-19-028524
Filing Date
2019-05-29
Accepted
2019-05-29 07:00:32
Documents
4
Period of Report
2019-05-29

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tv522563_6k.htm 6-K 13272
2 EXHIBIT 99.1 tv522563_ex99-1.htm EX-99.1 56115
3 EXHIBIT 99.2 tv522563_ex99-2.htm EX-99.2 29374
4 GRAPHIC image_001.jpg GRAPHIC 3887
  Complete submission text file 0001144204-19-028524.txt   105452
Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018
Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: 6-K | Act: 34 | File No.: 001-36288 | Film No.: 19859664
SIC: 2834 Pharmaceutical Preparations